274 related articles for article (PubMed ID: 33096752)
41. In situ labeling and imaging of cellular protein via a bi-functional anticancer aptamer and its fluorescent ligand.
Ai J; Li T; Li B; Xu Y; Li D; Liu Z; Wang E
Anal Chim Acta; 2012 Sep; 741():93-9. PubMed ID: 22840709
[TBL] [Abstract][Full Text] [Related]
42. Nucleolin targeting AS1411 modified protein nanoparticle for antitumor drugs delivery.
Wu J; Song C; Jiang C; Shen X; Qiao Q; Hu Y
Mol Pharm; 2013 Oct; 10(10):3555-63. PubMed ID: 23679916
[TBL] [Abstract][Full Text] [Related]
43. AS1411-conjugated gold nanospheres and their potential for breast cancer therapy.
Malik MT; O'Toole MG; Casson LK; Thomas SD; Bardi GT; Reyes-Reyes EM; Ng CK; Kang KA; Bates PJ
Oncotarget; 2015 Sep; 6(26):22270-81. PubMed ID: 26045302
[TBL] [Abstract][Full Text] [Related]
44. High affinity of AS1411 toward copper; its application in a sensitive aptasensor for copper detection.
Bahreyni A; Ramezani M; Alibolandi M; Hassanzadeh P; Abnous K; Taghdisi SM
Anal Biochem; 2019 Jun; 575():1-9. PubMed ID: 30926271
[TBL] [Abstract][Full Text] [Related]
45. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
[TBL] [Abstract][Full Text] [Related]
46. G-quartet oligonucleotide mediated delivery of proteins into photoreceptors and retinal pigment epithelium via intravitreal injection.
Leaderer D; Cashman SM; Kumar-Singh R
Exp Eye Res; 2016 Apr; 145():380-392. PubMed ID: 26923800
[TBL] [Abstract][Full Text] [Related]
47. Exploring New Potential Anticancer Activities of the G-Quadruplexes Formed by [(GTG
Virgilio A; Benigno D; Pecoraro A; Russo A; Russo G; Esposito V; Galeone A
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34208896
[TBL] [Abstract][Full Text] [Related]
48. Multi-targeted effects of G4-aptamers and their antiproliferative activity against cancer cells.
Ogloblina AM; Khristich AN; Karpechenko NY; Semina SE; Belitsky GA; Dolinnaya NG; Yakubovskaya MG
Biochimie; 2018 Feb; 145():163-173. PubMed ID: 29208488
[TBL] [Abstract][Full Text] [Related]
49. Novel diindoloazepinone derivatives as DNA minor groove binding agents with selective topoisomerase I inhibition: Design, synthesis, biological evaluation and docking studies.
Kadagathur M; Devi GP; Grewal P; Sigalapalli DK; Makhal PN; Banerjee UC; Bathini NB; Tangellamudi ND
Bioorg Chem; 2020 Jun; 99():103629. PubMed ID: 32272367
[TBL] [Abstract][Full Text] [Related]
50. Aptamer-integrated α-Gal liposomes as bispecific agents to trigger immune response for killing tumor cells.
Hong S; Ding P; Luo Y; Gao T; Zhang Y; Pei R
J Biomed Mater Res A; 2019 Jun; 107(6):1176-1183. PubMed ID: 30650243
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and biological evaluation of indeno[1,5]naphthyridines as topoisomerase I (TopI) inhibitors with antiproliferative activity.
Alonso C; Fuertes M; González M; Rubiales G; Tesauro C; Knudsen BR; Palacios F
Eur J Med Chem; 2016 Jun; 115():179-90. PubMed ID: 27017547
[TBL] [Abstract][Full Text] [Related]
52. Polypod-like structured guanine-rich oligonucleotide aptamer as a selective and cytotoxic nanostructured DNA to cancer cells.
Mohri K; Hayashi E; Nishino M; Matsushita N; Tanishita S; Nishikawa M; Sakuma S
J Drug Target; 2021 Feb; 29(2):217-224. PubMed ID: 32997541
[TBL] [Abstract][Full Text] [Related]
53. A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer.
Hwang DW; Ko HY; Lee JH; Kang H; Ryu SH; Song IC; Lee DS; Kim S
J Nucl Med; 2010 Jan; 51(1):98-105. PubMed ID: 20008986
[TBL] [Abstract][Full Text] [Related]
54. Nanoaggregate-forming lipid-conjugated AS1411 aptamer as a promising tumor-targeted delivery system of anticancer agents in vitro.
Carvalho J; Lopes-Nunes J; Vialet B; Rosado T; Gallardo E; Vale J; Eloy C; Ferreira S; Palmeira-de-Oliveira R; Campello MPC; Paulo A; Barthélémy P; Mergny JL; Salgado GF; Queiroz JA; Ellington AD; Cruz C
Nanomedicine; 2021 Aug; 36():102429. PubMed ID: 34174419
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis and biological evaluation of new β-carboline-bisindole compounds as DNA binding, photocleavage agents and topoisomerase I inhibitors.
Kovvuri J; Nagaraju B; Nayak VL; Akunuri R; Rao MPN; Ajitha A; Nagesh N; Kamal A
Eur J Med Chem; 2018 Jan; 143():1563-1577. PubMed ID: 29129513
[TBL] [Abstract][Full Text] [Related]
56. Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.
Zhuang Y; Deng H; Su Y; He L; Wang R; Tong G; He D; Zhu X
Biomacromolecules; 2016 Jun; 17(6):2050-62. PubMed ID: 27113017
[TBL] [Abstract][Full Text] [Related]
57. AS1411 aptamer modified carbon dots via polyethylenimine-assisted strategy for efficient targeted cancer cell imaging.
Kong T; Zhou R; Zhang Y; Hao L; Cai X; Zhu B
Cell Prolif; 2020 Jan; 53(1):e12713. PubMed ID: 31691382
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II.
Zhuo ST; Li CY; Hu MH; Chen SB; Yao PF; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS
Org Biomol Chem; 2013 Jun; 11(24):3989-4005. PubMed ID: 23657605
[TBL] [Abstract][Full Text] [Related]
59. Investigation of acetylcholinesterase and mammalian DNA topoisomerases, carbonic anhydrase inhibition profiles, and cytotoxic activity of novel bis(α-aminoalkyl)phosphinic acid derivatives against human breast cancer.
Dastan T; Kocyigit UM; Durna Dastan S; Canturk Kilickaya P; Taslimi P; Cevik O; Koparir M; Orek C; Gulçin İ; Cetin A
J Biochem Mol Toxicol; 2017 Nov; 31(11):. PubMed ID: 28833991
[TBL] [Abstract][Full Text] [Related]
60. Nucleolin-targeted Extracellular Vesicles as a Versatile Platform for Biologics Delivery to Breast Cancer.
Wang Y; Chen X; Tian B; Liu J; Yang L; Zeng L; Chen T; Hong A; Wang X
Theranostics; 2017; 7(5):1360-1372. PubMed ID: 28435471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
